China Resources Wandong Medical Equipment Co.,Ltd (01093): The application for the listing of Palivizumab injection has been accepted by the National Medical Products Administration.

Wisdom Financial App News, Shiyao Group (01093) announced that its subsidiary, Shiyao Group Jushi Biopharmaceutical Co., Ltd., has submitted an application for the listing of pertuzumab injection (the product), which has been accepted by the National Medical Products Administration of the People's Republic of China. The product is classified as a therapeutic biological product under category 3.3, indicated for HER2-positive breast cancer.